NL-OMON54970招募中不适用
Targeted correction of plasma sodium levels in hospitalized patients with hyponatremia: a randomized, controlled, parallel-group trial with blinded outcome assessment - HIT-trial
efrologie0 个研究点目标入组 1,000 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 1,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •All adult hospitalised patients with hypotonic hyponatremia <130mmol/l
排除标准
- •Severe symptomatic hyponatremia in need of intensive care treatment and / or
- •of acute correction with 3% saline
- •Non-hypotonic hyponatremia with plasma osmolality >300 mOsm
- •End of life care (palliative treatment)
- •End stage kidney disease (dialysis)
- •Acute liver failure
- •Wernicke encephalopathy
- •Hepatic encephalopathy during last 2 months
- •Hepatorenal syndrome
- •Patients in the isolation ward due to haematological diseases
- •Pregnancy / breastfeeding
- •Patients hospitalized for a predetermined fixed duration of 3 days or less
- •(e.g. inpatient chemotherapy treatment)
研究者
相似试验
已完成
不适用
Targeted Correction of Plasma Sodium Levels in Hospitalized Patients With HyponatremiaHyponatremiaNCT03557957University Hospital, Basel, Switzerland2,278
尚未招募
不适用
Efforts to reduce daily salt consumption through awareness generation by community health workersCTRI/2020/06/025591Vital Strategies
进行中（未招募）
不适用
THE BALANCE study: Treatment of Hyponatremia based on Lixivaptan in NYHA class III/IV Cardiac Patient Evaluation - CK-LX3401Hyponatremia in NYHA Class III/IV Cardiac PatientMedDRA version: 9.1Level: LLTClassification code 10021036Term: HyponatraemiaEUCTR2006-002567-62-ITCARDIOKINE BIOPHARMA, LLC650
尚未招募
不适用
Correction of Hypernatremia by Intravenous Hypotonic Solution Compared to Enteral WaterHypernatremiaNCT06061783Hospital Civil de Guadalajara178
已完成
不适用
The effects of a salt substitute on an Iranian population.Hypertension.Essential (primary) hypertensionIRCT2016103130572N1Research Deputy of Medicine Faculty, Tehran Universiy of Medical Sciences250